Postmortem studies of patients with schizophrenia show reduced expression of insulin receptors and signaling molecules (e.g., AKT, GSK3β, mTOR) in the frontal cortex, indicating impaired brain insulin sensitivity [134,135,136]. This evidence concerns the gene INS and schizophrenia.